BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8911290)

  • 21. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
    Halperin EC; Hutchison P; Barrier RC
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
    Chakrabarti A; Fleisher WP; Staley D; Calhoun L
    Ann R Coll Physicians Surg Can; 2002 Dec; 35(8 Suppl.):541-6. PubMed ID: 15015500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between pharmaceutical representatives and doctors in training. A thematic review.
    Zipkin DA; Steinman MA
    J Gen Intern Med; 2005 Aug; 20(8):777-86. PubMed ID: 16050893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caring for older patients: current attitudes and future plans of family medicine residents.
    Helton MR; Pathman DE
    Fam Med; 2008; 40(10):707-14. PubMed ID: 18979258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coping strategies, depression, and anxiety among Ontario family medicine residents.
    Earle L; Kelly L
    Can Fam Physician; 2005 Feb; 51(2):242-3. PubMed ID: 16926935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical representatives and emergency medicine residents: a national survey.
    Reeder M; Dougherty J; White LJ
    Ann Emerg Med; 1993 Oct; 22(10):1593-6. PubMed ID: 8214843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determining an ethical stance. Pharmaceutical industry involvement and family medicine residency training.
    Guyatt G
    Can Fam Physician; 1997 Nov; 43():1898-900, 1905-7. PubMed ID: 9386871
    [No Abstract]   [Full Text] [Related]  

  • 30. Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry.
    Hyman PL; Hochman ME; Shaw JG; Steinman MA
    Acad Med; 2007 Jan; 82(1):94-9. PubMed ID: 17198299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do ethical Guidelines make a difference to decision-making?
    Osborn M; Day R; Komesaroff P; Mant A
    Intern Med J; 2009 Dec; 39(12):800-5. PubMed ID: 19323704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between emergency medicine programs and the pharmaceutical industry.
    Keim SM; Mays MZ; Grant D
    Acad Emerg Med; 2004 Jan; 11(1):19-26. PubMed ID: 14709424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical industry interactions in family medicine residencies decreased between 2008 and 2013: a CERA study.
    Brown SR; Evans DV; Fugh-Berman A
    Fam Med; 2015 Apr; 47(4):279-82. PubMed ID: 25853598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Closing the door on pharma? A national survey of family medicine residencies regarding industry interactions.
    Fugh-Berman A; Brown SR; Trippett R; Bell AM; Clark P; Fleg A; Siwek J
    Acad Med; 2011 May; 86(5):649-54. PubMed ID: 21436662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intention to relocate to the United States.
    Ma PC; Chan LK; Huynh X
    Can Fam Physician; 1997 Sep; 43():1533-9. PubMed ID: 9303232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
    Castresana L; Mejia R; Aznar M
    Medicina (B Aires); 2005; 65(3):247-51. PubMed ID: 16042137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survey of osteopathic and allopathic residents' attitudes toward osteopathic manipulative treatment.
    Allee BA; Pollak MH; Malnar KF
    J Am Osteopath Assoc; 2005 Dec; 105(12):551-61. PubMed ID: 16424465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attitudes of general practitioners in New Zealand to pharmaceutical representatives.
    Thomson AN; Craig BJ; Barham PM
    Br J Gen Pract; 1994 May; 44(382):220-3. PubMed ID: 8204336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Counseling regarding pregnancy--related drug exposures by family physicians in Ontario.
    Goodwin J; Rieder S; Rieder MJ; Matsui D
    Can J Clin Pharmacol; 2007; 14(1):e58-69. PubMed ID: 17314415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Physicians and drug industry: attitudes and practice].
    Aasland OG; Førde R
    Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2603-6. PubMed ID: 15534631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.